| Dr Darius G Aliabadi, MD | |
|
1118 Ross Clark Cir, Suite 403, Dothan, AL 36301-3001 | |
| (334) 793-5672 | |
| (334) 794-0378 |
| Full Name | Dr Darius G Aliabadi |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 35 Years |
| Location | 1118 Ross Clark Cir, Dothan, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700831047 | NPI | - | NPPES |
| 32555 PMD | Other | AL | BCBS OF AL # & TYPE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 20757 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southeast Alabama Medical Center | Dothan, AL | Hospital |
| Northwest Florida Community Hospital | Chipley, FL | Hospital |
| Dale Medical Center | Ozark, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hearts South Pc | 7810933751 | 7 |
| Houston County Healthcare Authority | 9436062296 | 196 |
News Archive
Arrowhead Pharmaceuticals Inc. today announced that it has completed dosing of a Phase 1 clinical study of ARO-AAT, the company's second generation subcutaneously administered RNA interference therapeutic being developed as a treatment for a rare genetic liver disease associated with alpha-1 antitrypsin deficiency.
Like all industries, the medical device sector is constantly seeking to align its marketing staffing levels to optimal organizational performance. A recent study by Best Practices, LLC found that strategic marketers in the medical device sector typically support about 10 products per marketer, indicating portfolio prioritization is essential to success.
A team of researchers in Italy and Austria has determined that a drug approved to treat chronic lymphocytic leukemia (CLL) may be less effective in a particular subset of patients.
A scientific team at Harvard-affiliated medical centers genetically manipulated mice to age faster. Then they used gene therapy to lengthen telomeres. Telomeres are compounds found at the ends of strands of DNA that are related to age. This lengthening of telomeres reversed age-related problems such as decreased brain function and infertility.
A new understanding of an enzyme important for the transfer of genetic information in bacteria may help scientists improve current antibiotics and also create antibiotics that are less vulnerable to resistance.
› Verified 1 days ago
| Entity Name | Houston County Healthcare Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619026606 PECOS PAC ID: 9436062296 Enrollment ID: O20040219000209 |
News Archive
Arrowhead Pharmaceuticals Inc. today announced that it has completed dosing of a Phase 1 clinical study of ARO-AAT, the company's second generation subcutaneously administered RNA interference therapeutic being developed as a treatment for a rare genetic liver disease associated with alpha-1 antitrypsin deficiency.
Like all industries, the medical device sector is constantly seeking to align its marketing staffing levels to optimal organizational performance. A recent study by Best Practices, LLC found that strategic marketers in the medical device sector typically support about 10 products per marketer, indicating portfolio prioritization is essential to success.
A team of researchers in Italy and Austria has determined that a drug approved to treat chronic lymphocytic leukemia (CLL) may be less effective in a particular subset of patients.
A scientific team at Harvard-affiliated medical centers genetically manipulated mice to age faster. Then they used gene therapy to lengthen telomeres. Telomeres are compounds found at the ends of strands of DNA that are related to age. This lengthening of telomeres reversed age-related problems such as decreased brain function and infertility.
A new understanding of an enzyme important for the transfer of genetic information in bacteria may help scientists improve current antibiotics and also create antibiotics that are less vulnerable to resistance.
› Verified 1 days ago
| Entity Name | Hearts South Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790987238 PECOS PAC ID: 7810933751 Enrollment ID: O20050630001066 |
News Archive
Arrowhead Pharmaceuticals Inc. today announced that it has completed dosing of a Phase 1 clinical study of ARO-AAT, the company's second generation subcutaneously administered RNA interference therapeutic being developed as a treatment for a rare genetic liver disease associated with alpha-1 antitrypsin deficiency.
Like all industries, the medical device sector is constantly seeking to align its marketing staffing levels to optimal organizational performance. A recent study by Best Practices, LLC found that strategic marketers in the medical device sector typically support about 10 products per marketer, indicating portfolio prioritization is essential to success.
A team of researchers in Italy and Austria has determined that a drug approved to treat chronic lymphocytic leukemia (CLL) may be less effective in a particular subset of patients.
A scientific team at Harvard-affiliated medical centers genetically manipulated mice to age faster. Then they used gene therapy to lengthen telomeres. Telomeres are compounds found at the ends of strands of DNA that are related to age. This lengthening of telomeres reversed age-related problems such as decreased brain function and infertility.
A new understanding of an enzyme important for the transfer of genetic information in bacteria may help scientists improve current antibiotics and also create antibiotics that are less vulnerable to resistance.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Darius G Aliabadi, MD 1118 Ross Clark Cir, Suite 403, Dothan, AL 36301-3001 Ph: (334) 793-5672 | Dr Darius G Aliabadi, MD 1118 Ross Clark Cir, Suite 403, Dothan, AL 36301-3001 Ph: (334) 793-5672 |
News Archive
Arrowhead Pharmaceuticals Inc. today announced that it has completed dosing of a Phase 1 clinical study of ARO-AAT, the company's second generation subcutaneously administered RNA interference therapeutic being developed as a treatment for a rare genetic liver disease associated with alpha-1 antitrypsin deficiency.
Like all industries, the medical device sector is constantly seeking to align its marketing staffing levels to optimal organizational performance. A recent study by Best Practices, LLC found that strategic marketers in the medical device sector typically support about 10 products per marketer, indicating portfolio prioritization is essential to success.
A team of researchers in Italy and Austria has determined that a drug approved to treat chronic lymphocytic leukemia (CLL) may be less effective in a particular subset of patients.
A scientific team at Harvard-affiliated medical centers genetically manipulated mice to age faster. Then they used gene therapy to lengthen telomeres. Telomeres are compounds found at the ends of strands of DNA that are related to age. This lengthening of telomeres reversed age-related problems such as decreased brain function and infertility.
A new understanding of an enzyme important for the transfer of genetic information in bacteria may help scientists improve current antibiotics and also create antibiotics that are less vulnerable to resistance.
› Verified 1 days ago
Parks Winfield Pratt Iii, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4300 W Main St, Suite 102, Dothan, AL 36305 Phone: 334-793-9564 Fax: 334-671-8907 | |
Mr. Rodney K Beauchamp, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 200 Parkwest Cir Ste 2, Dothan, AL 36303 Phone: 334-699-2004 | |
Brian Reynolds Sinclair, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1450 Ross Clark Cir Ste 400, Dothan, AL 36301 Phone: 334-305-0400 Fax: 334-305-0401 | |
Dr. Olawale Mayokun Osunsanya, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1763 E Main St, Dothan, AL 36301 Phone: 334-793-3319 Fax: 334-793-2291 | |
Jeffrey John Crittenden, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 480 Honeysuckle Rd, Dothan, AL 36305 Phone: 334-836-1212 Fax: 334-836-1888 | |
Dr. Venkat R Nimmagadda, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1540 E Main St, Dothan, AL 36301 Phone: 334-793-2618 Fax: 334-792-7353 | |
Christopher O. Ike, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4300 W Main St Ste 102, Dothan, AL 36305 Phone: 334-793-9564 Fax: 334-340-2805 |